6-Month Outcomes: What to Expect From Your Regenerative Medicine Treatment

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

Here's a conversation I have almost every week. A patient comes in around the five or six month mark after a PRP or stem cell procedure, settles into the chair, and says something like, "Doc, I think it's working, but I'm honestly not sure." They're moving better. They've stopped reaching for ibuprofen every single morning. But they expected something more dramatic, more like flipping a switch, and nobody ever told them what the slow version of success actually looks like.

That gap between expectation and reality is the single biggest reason people feel let down by regenerative medicine, even when their treatment is doing exactly what it's supposed to do. So let's close that gap. I'm Dr. Farhan Abdullah, and at Magnolia Functional Wellness in Southlake, I spend a good chunk of my week helping patients understand not just what these therapies do, but when they do it. Six months is a meaningful checkpoint. It's long enough for real biology to show up, and short enough that you're still paying close attention. Knowing what to expect at that point changes how you read your own progress.

The Regenerative Timeline Isn't What Most People Expect

When you take an anti-inflammatory or get a cortisone shot, the mechanism is simple. You're suppressing something. Relief shows up fast because you're turning down the volume on pain signals and calming inflammation. Regenerative treatments work in almost the opposite direction. Platelet-rich plasma, bone marrow concentrate, adipose-derived cells, exosomes, none of these are suppressing anything. They're trying to recruit your own body into a repair and remodeling process. And repair runs on biology's clock, not ours.

Think about what actually has to happen inside a joint or a tendon. Growth factors and signaling molecules get delivered. Local cells wake up and respond. Inflammation shifts from the destructive kind toward the constructive kind. New collagen gets laid down, and then it has to mature, organize, and gain tensile strength. That last part alone, the remodeling of collagen, can take months. So when a patient tells me they felt "nothing" at week three, I'm not worried. Week three is early. The interesting work is still being built.

What I tell my patients is to stop thinking in days and start thinking in phases. There's an early inflammatory and recruitment phase in the first few weeks. There's a proliferation phase where tissue is actively being rebuilt, roughly weeks four through twelve. Then there's a long remodeling phase that stretches well past the six month mark. Your symptoms don't improve in a straight line across those phases. They tend to move in steps, with plateaus in between, and that's completely normal. A plateau isn't a stall. It's often just the quiet part of the work.

Month by Month: What the First Six Months Usually Look Like

Every patient is different, and the joint or tissue being treated matters a great deal. A rotator cuff tendon and an arthritic knee don't follow identical timelines. Still, there's a general arc I see often enough that it's worth walking through.

Weeks 1 through 4

This stretch can be counterintuitive. Some patients feel a bit more sore for the first week or two, especially after bone marrow or adipose-based procedures, because we've deliberately kicked off an inflammatory signal. That soreness isn't a setback. It's the process starting. By the end of the first month, a lot of people notice the treated area simply feels different, sometimes calmer, sometimes just less reactive to the things that used to flare it up. Dramatic pain relief this early is the exception, not the rule, so don't let a quiet month one discourage you.

Months 2 and 3

This is usually when the first real signals show up. Patients start telling me they forgot to take their morning anti-inflammatory, or they went up the stairs without thinking about it, or they slept through the night without the joint waking them. The improvements at this stage are often about function and frequency more than raw pain scores. You're not necessarily pain free. You're having fewer bad days and more good ones, and that shift is the foundation everything else gets built on.

Months 4 through 6

For many people, this is where the treatment really declares itself. The bulk of the proliferation work is done, remodeling is well underway, and the cumulative effect becomes hard to ignore. By month six, I want to sit down with a patient and compare them honestly to where they started. Not to where they hoped to be, to where they actually were. More often than not, the difference is real and substantial. They're doing things they'd quietly stopped doing without ever announcing it, even to themselves. I've had patients who, by the six month visit, finally got back to walking the full Southlake Town Square loop without mentally mapping out where every bench is.

What the Research Actually Shows at the Six-Month Mark

I think it's worth being straight with you about the evidence, because regenerative medicine gets oversold in some corners and dismissed too quickly in others. The honest picture sits in the middle, and it's genuinely encouraging if you read it carefully.

On the cell therapy side, a phase IIb randomized, double-blind, placebo-controlled trial by Lee and colleagues, published in Stem Cells Translational Medicine in 2019, looked at a single injection of adipose-derived mesenchymal stem cells for knee osteoarthritis. At six months, the treated group showed significant improvement in WOMAC scores, the standard measure of arthritis pain and function, while the saline control group did not. Just as telling, MRI showed the cartilage defect held steady in the treatment group while it worsened in the control group. Six months was enough time to see both a symptom benefit and a structural one. You can read the trial summary here.

A more recent randomized, double-blind controlled trial by Lee and colleagues in Cell Transplant, published in 2025, tested allogeneic bone marrow-derived stem cells for knee osteoarthritis. The treatment group showed meaningful between-group improvement in WOMAC and KOOS scores by nine months, and quantitative T2 MRI mapping suggested the cells slowed cartilage degradation out to twelve months. The pattern there matters. The structural protection was measurable before patients felt completely maxed out on symptom relief, which fits exactly with what I see in clinic. The joint is being protected even while it's still catching up on how it feels.

PRP is a little messier in the literature, and I'd rather you hear that from me than be blindsided by it later. A large 2023 systematic review and meta-analysis in Frontiers in Medicine by Xiong and colleagues pooled 24 randomized trials and found that PRP significantly improved pain and function scores in knee osteoarthritis, with leukocyte-poor preparations outperforming leukocyte-rich ones. But the well-run RESTORE trial published in JAMA, also using leukocyte-poor PRP, found no significant difference versus saline at twelve months. So what do I take from all that? PRP helps a lot of people, the preparation and the patient selection matter enormously, and a single protocol isn't right for every joint or every grade of arthritis. Sorting through that nuance is the whole job.

When Six Months Doesn't Deliver What You Hoped

Let's talk about the patients who reach the six month mark and feel underwhelmed, because they exist and they deserve a plan, not a shrug.

First, I want to separate "no improvement at all" from "less improvement than I wanted." Those are different problems with different solutions. True non-responders are relatively uncommon, but they happen, and when they do, the answer is usually one of a few things. The joint may be further along structurally than the initial imaging suggested. The biologic dose or type may not have matched the target well. Or there's a driver we didn't fully address, like an unstable joint, a muscular imbalance, or a metabolic factor such as poorly controlled blood sugar that quietly works against tissue repair the entire time.

This is exactly why I treat regenerative procedures as one part of a plan rather than a standalone event. Sometimes the right move at six months is a second, targeted treatment, since several of these therapies are designed to build on each other. Sometimes it's adding focused rehab, because no injection on earth fixes a bad movement pattern. And sometimes it's a more honest conversation about whether a structural problem has crossed the line where surgery is genuinely the better tool. I'd rather have that conversation with you directly than watch you keep chasing diminishing returns. If you want to understand how we think about the underlying procedures, our overview of orthobiologics in Southlake lays out the options we actually use and who they tend to help.

The other thing I'll say, gently, is that "less than I hoped" often reflects an expectation problem more than a treatment failure. If you walked in expecting a brand new knee and instead you got a knee that lets you hike, garden, and sleep through the night, that's not a failure. That's a meaningful win that got measured against the wrong yardstick.

How We Measure Success at Your Six-Month Check-In

So how should you actually judge your results? I lean on a handful of questions, and I'd encourage you to use them too, because they keep the assessment honest and grounded.

What can you do now that you'd stopped doing? This one matters more than any single pain number, because it captures real life: stairs, sleep, getting up off the floor, a full round of golf, picking up a grandkid without bracing for it. How often do you have a bad day compared to before? Frequency usually tells you more than peak intensity. What's happened to your medication use? If you've quietly cut your anti-inflammatory or pain medication in half, that's hard data. And if we have follow-up imaging, what is the structure doing? Holding steady is a legitimate result in a degenerative condition that is, by definition, supposed to keep getting worse.

In my practice, I'll often ask patients to keep a simple log between visits, even just a running note on their phone, because memory is a genuinely terrible measuring tool. We're wired to remember the flare-ups and forget the ordinary good days. A log catches the good days. When we sit down at six months and look at it together, the trend is usually clearer than either of us expected going in. For joint and tendon issues specifically, that six month review is also when we decide whether a follow-up PRP injection makes sense or whether you're better off simply protecting and building on the gains you've already made.

Here's the practical takeaway. Six months into a regenerative treatment, you're not looking for a miracle, you're looking for a trajectory. Are you trending toward more function, fewer bad days, and less reliance on medication? If so, the biology is doing its work, even if it never felt as cinematic as you pictured it. If you're not seeing that trend, that's not the end of the story either, it's a signal to reassess and adjust. Either way, the six month checkpoint is meant to be a real conversation, not a rubber stamp. That's how we approach it at Magnolia Functional Wellness here in Southlake, and it's the difference between guessing about your results and actually understanding them.